Revenue

Friedman Industries just announced its 218th straight quarterly dividend, a rare feat. But what does this signal of reliability mean amid industry shifts and questions about its cash flow?

After a Q1 revenue miss, all eyes are on ICF's upcoming Q2 results. Can its booming commercial energy sector offset federal headwinds and validate its ambitious 2026 guidance?

The FDA has approved TRYNGOLZA, the first drug to reduce triglycerides and acute pancreatitis risk, marking a new era for millions and a pivotal moment for Ionis.

Kadima Neuropsychiatry sues NRx Pharma, alleging deceit in a failed acquisition. The case reveals the high stakes of corporate integrity and financial truth.

EDF's €1 billion dividend to the French state signals financial health, but raises questions about its balancing act with massive energy transition investments.

With a $450M war chest, Opifex-Synergy is arming itself to challenge giants in the booming equipment rental market fueling U.S. infrastructure growth.

With its crucial Jet.AI merger vote adjourned to the wire, flyExclusive touts record operations. But can the tech acquisition reverse a 50% stock slide?

As American Express preps its Q2 earnings call, investors are watching more than just numbers. At stake is a verdict on consumer spending, travel, and tech strategy.

As the pet industry booms, Pet Supplies Plus and Wag N' Wash unveil a cost-cutting plan to scale faster. But does growth translate to profit for all franchisees?

Stitch Fix's new AI lets you see outfits on your own image before you buy. We explore if this tech is a gimmick or the key to solving online shopping's biggest problems.

As co-founder Scott Morris steps back, Freshpet marks 20 years by promoting new leaders to navigate a booming market and redefine pet nutrition's future.

As LivaNova preps its Q2 2026 report, all eyes are on its growth in neuromodulation and cardiac care. Will innovation continue to drive its success?

A single tanker's safe passage reveals a startling truth: in 2026, geopolitical turmoil isn't just a risk, it's a business model for the global shipping elite.

A massive shareholder lock-up at One and One Green Technologies signals deep confidence. But is it just a stock play, or a sign of a deeper revolution in sustainable industry?

Replenish Nutrients is partnering with Hutterite colonies to build a decentralized production network. Is this a new model for capital-light industrial growth?

Incoming Nuwellis CEO Mike McCormick lays out a bold growth plan targeting critically ill children, but a closer look reveals a precarious financial balancing act.

The mining giant’s dividend boost isn't just a shareholder reward; it's a bold signal of confidence in a supercharged copper market. What's the story here?

Bionano Genomics brings back OGM pioneer Dr. Alex Hastie as CSO. It's a strategic move to accelerate clinical adoption and restore investor confidence.

As automation floods the ad world, Bottle Rocket Media's handcrafted anniversary campaign argues that human creativity delivers an ROI that algorithms can't match.

Canaan's CEO and CFO just bought over a million shares. Is this a signal of deep value or a risky bet on a new strategy in a volatile market?